BioAtla is a clinical-stage biotechnology company that develops antibody-based therapeutics for cancer treatment. Its research focuses on conditionally active biologic candidates designed to target tumor environments while limiting effects on healthy tissue.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!